Ken Haas has spent 25 years in the management of both early-stage and public high technology and biotechnology companies. Mr. Haas’ role is to identify, invest in and provide support for portfolio companies. He was part of the founding management team at IntelliGenetics, one of the world’s first bioinformatics companies, and chief executive officer of IntelliCorp, a publicly-traded enterprise software company. At the beginning of his career, he practiced as an attorney in the business and technology group of Heller, Ehrman, White & McAuliffe and has been co-chair of the advisory council to the Neuroscience Institute at Stanford. He received his B.A. from Harvard College, an M.A. from the University of Sussex and a J.D. from Harvard Law School.